細胞内癌原遺伝子タンパク質を利用した細胞毒性タンパク質の放出
Matthias Schild1, Dennis Gillingham1
1Department of Chemistry, University of Basel 4056 Basel Switzerland dennis.gillingham@unibas.ch.
Abstract:
The success of antibody-drug conjugates has demonstrated the value of targeted delivery strategies for cytotoxic molecules. However, many oncogenic drivers remain inaccessible to antibodies due to their intracellular location, and these drivers are currently mainly addressed using small molecule inhibitors. This work explores repurposing such inhibitors for the intracellular delivery and controlled release of cytotoxic payloads. Using click-to-release chemistry, a pre-targeting strategy was developed where inhibitor-tetrazine conjugates enable selective activation of systemically administered trans-cyclooctene (TCO) caged prodrugs. This concept was demonstrated using the epidermal growth factor receptor (EGFR), a key therapeutic target in non-small cell lung cancer. An afatinib-tetrazine conjugate achieved sufficient intracellular retention in EGFR-overexpressing cells to enable toxicity recovery from a TCO-protected monomethyl auristatin E (MMAE) derivative. Successful intracellular targeting and controlled payload release establish a foundation for expanding the scope of targeted drug delivery to previously inaccessible oncogenic drivers.
関連する概念動画
04:58Isolation of Cell-Surface and Intracellular Proteins from an Astrocyte Culture
10:26Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions
Intracellular Signaling Cascades
10:08Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
03:14Measuring Mast Cell Exocytosis via Neuropeptide Y Monomeric Red Fluorescent Protein Release
09:03Exploiting Live Imaging to Track Nuclei During Myoblast Differentiation and Fusion


